Connor, Clark & Lunn Investment Management Ltd. Repare Therapeutics Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$4.53 - $8.41 $41,209 - $76,505	9,097 Added 54.38%	25,826 $121,000
Q4 2023 Feb 09, 2024	BUY	$3.22 - $11.79 $5,828 - $21,339	1,810 Added 12.13%	16,729 $122,000
Q3 2023 Nov 13, 2023	BUY	$8.16 - $13.01 $28,502 - $45,443	3,493 Added 30.57%	14,919 $180,000
Q2 2023 Aug 10, 2023	BUY	$8.63 - $12.53 $98,606 - $143,167	11,426 New	11,426 $120,000

Others Institutions Holding RPTX

# of Institutions

Shares Held

35.4M

Call Options Held

50K

Put Options Held

300

Bvf Inc San Francisco, CA

10.3M
Shares

$14.3 Million
1.13% of portfolio
Blue Owl Capital Holdings LP New York, NY

3.37M
Shares

$4.65 Million
3.82% of portfolio
Orbimed Advisors LLC San Diego, CA

3.32M
Shares

$4.59 Million
0.27% of portfolio
Chi Advisors LLC New York, NY

2.97M
Shares

$4.09 Million
17.66% of portfolio
Versant Venture Management, LLC San Francisco, CA

2.65M
Shares

$3.65 Million
23.86% of portfolio

View Full List

About Repare Therapeutics Inc.

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $57.9M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

More about RPTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account